Resistance to endotoxin shock in transgenic mice overexpressing endothelial nitric oxide synthase. 2000

T Yamashita, and S Kawashima, and Y Ohashi, and M Ozaki, and T Ueyama, and T Ishida, and N Inoue, and K Hirata, and H Akita, and M Yokoyama
First Department of Internal Medicine, Kobe University School of Medicine, Kobe, Japan.

BACKGROUND Nitric oxide (NO) plays a central role in the pathogenesis of septic shock. However, the role of the NO produced by endothelial NO synthase (eNOS) in septic shock is still unclear. We examined the effect of chronic eNOS overexpression and the role of eNOS-derived NO in lipopolysaccharide (LPS)-induced septic shock using eNOS transgenic (Tg) mice. RESULTS LPS was intraperitoneally injected into Tg and control mice. No differences existed in the peak plasma nitrate and nitrate levels induced by LPS between the 2 genotypes. In LPS-treated control mice, blood pressure progressively declined and reached 60% of basal levels (from 97+/-3 to 59+/-3 mm Hg) 24 hours after LPS injection. In contrast, the blood pressure of LPS-treated Tg mice fell only 15% from basal levels (from 84+/-4 to 71+/-4 mm Hg) after the first 6 hours and, thereafter, it remained at this level. LPS-induced increases in the expression of the mRNA of both vascular cell adhesion molecule-1 and intracellular adhesion molecule-1 in the lungs were significantly lower in Tg mice than in control mice. LPS-induced pulmonary leukocyte infiltration and increases in lung water content were also significantly attenuated in Tg mice. Histological examination revealed that lung injury after LPS injection was milder in Tg mice. Furthermore, Tg mice exhibited enhanced survival from LPS-induced septic shock compared with control mice. CONCLUSIONS Chronic eNOS overexpression in the endothelium of mice resulted in resistance to LPS-induced hypotension, lung injury, and death. These effects are associated with the reduced vascular reactivity to NO and the reduced anti-inflammatory effects of NO.

UI MeSH Term Description Entries
D007022 Hypotension Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients. Blood Pressure, Low,Hypotension, Vascular,Low Blood Pressure,Vascular Hypotension
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D009102 Multiple Organ Failure A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative. MODS,Multiple Organ Dysfunction Syndrome,Organ Dysfunction Syndrome, Multiple,Organ Failure, Multiple,Failure, Multiple Organ,Multiple Organ Failures
D009195 Peroxidase A hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7. Myeloperoxidase,Hemi-Myeloperoxidase,Hemi Myeloperoxidase
D009566 Nitrates Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical. Nitrate

Related Publications

T Yamashita, and S Kawashima, and Y Ohashi, and M Ozaki, and T Ueyama, and T Ishida, and N Inoue, and K Hirata, and H Akita, and M Yokoyama
August 2007, American journal of physiology. Heart and circulatory physiology,
T Yamashita, and S Kawashima, and Y Ohashi, and M Ozaki, and T Ueyama, and T Ishida, and N Inoue, and K Hirata, and H Akita, and M Yokoyama
November 2010, Pflugers Archiv : European journal of physiology,
T Yamashita, and S Kawashima, and Y Ohashi, and M Ozaki, and T Ueyama, and T Ishida, and N Inoue, and K Hirata, and H Akita, and M Yokoyama
March 2007, Journal of the American Society of Nephrology : JASN,
T Yamashita, and S Kawashima, and Y Ohashi, and M Ozaki, and T Ueyama, and T Ishida, and N Inoue, and K Hirata, and H Akita, and M Yokoyama
March 1993, British journal of pharmacology,
T Yamashita, and S Kawashima, and Y Ohashi, and M Ozaki, and T Ueyama, and T Ishida, and N Inoue, and K Hirata, and H Akita, and M Yokoyama
November 2004, American journal of physiology. Renal physiology,
T Yamashita, and S Kawashima, and Y Ohashi, and M Ozaki, and T Ueyama, and T Ishida, and N Inoue, and K Hirata, and H Akita, and M Yokoyama
October 2003, The American journal of pathology,
T Yamashita, and S Kawashima, and Y Ohashi, and M Ozaki, and T Ueyama, and T Ishida, and N Inoue, and K Hirata, and H Akita, and M Yokoyama
July 2001, Circulation,
T Yamashita, and S Kawashima, and Y Ohashi, and M Ozaki, and T Ueyama, and T Ishida, and N Inoue, and K Hirata, and H Akita, and M Yokoyama
May 1992, Cardiovascular research,
T Yamashita, and S Kawashima, and Y Ohashi, and M Ozaki, and T Ueyama, and T Ishida, and N Inoue, and K Hirata, and H Akita, and M Yokoyama
January 1998, The Journal of biological chemistry,
T Yamashita, and S Kawashima, and Y Ohashi, and M Ozaki, and T Ueyama, and T Ishida, and N Inoue, and K Hirata, and H Akita, and M Yokoyama
January 2006, Surgery today,
Copied contents to your clipboard!